NCT00312325
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +17 more
- Locations
-
- Department of Clinical Pharmacology Vienna, Austria
Clinical trial condition
Thyroid Diseases
Explore clinical trials studying Thyroid Diseases. Study availability and eligibility vary by location and protocol.
1,049 public trials
244 recruiting studies
Thyroid Diseases trial results
NCT00150137
- Conditions
- Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
- Locations
-
- Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark
NCT00148213
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +4 more
- Locations
-
- Department of Nuclear Medicine, Münster University Hospital Münster, Germany
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
NCT04521686
- Conditions
- Adenocarcinoma, Any Solid Tumor, Astrocytoma, +49 more
- Locations
-
- Mayo Clinic of Scottsdale Phoenix, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- USC Norris Cancer Hospital Los Angeles, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
Active, Not Recruiting
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
NCT06248619
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
- Locations
-
- Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
- Advanced Quality Medical Research Orland Park, Illinois, United States
- W Kellogg Eye Center Ann Arbor, Michigan, United States
- Las Vegas Endocrinology Henderson, Nevada, United States
Active, Not Recruiting
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
- Conditions
- Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
NCT07023731
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
- Locations
-
- Clinical Trial Site Phoenix, Arizona, United States
- Clinical Trial Site Phoenix, Arizona, United States
- Clinical Trial Site New Haven, Connecticut, United States
- Clinical Trial Site Tampa, Florida, United States